510(k) Report

510(k) · Cleared

Cleared

Clearlight Phototheraphy System, Model CL 420

K013623510(k) TraditionalCleared Aug 16, 2002284-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Curelight, Ltd. · GEX Powered Laser Surgical Instrument

Cleared on Aug 16, 2002 after a 284-day review. The FDA summary names its predicate without a number. 856 later devices descend from it.

Decided
Aug 16, 2002
Review
284 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
0

856 later devices descend from it, 10 citing it directly.

Descendants, by year cleared 2005: 9 descendants cleared2004: 5 descendants cleared2007: 15 descendants cleared2006: 8 descendants cleared2003: 1 descendant cleared2008: 28 descendants cleared2009: 13 descendants cleared2017: 42 descendants cleared2010: 22 descendants cleared2021: 43 descendants cleared2012: 18 descendants cleared2011: 17 descendants cleared2013: 27 descendants cleared2015: 33 descendants cleared2016: 41 descendants cleared2023: 55 descendants cleared2020: 46 descendants cleared2018: 38 descendants cleared2022: 61 descendants cleared2019: 31 descendants cleared2024: 86 descendants cleared2014: 29 descendants cleared2025: 118 descendants cleared2026: 70 descendants cleared200020052010201520202025
  1. This deviceK013623 Clearlight Phototheraphy System, Model CL 420Curelight, Ltd. · 2002
  2. Descendant · cites it directly · 737 of its ownK033946 Lovely SystemMsq (M2), Ltd. · 2004
  3. Descendant · cites it directly · 524 of its ownK030883 Omnilux BluePhoto Therapeutics Limited · 2003
  4. Descendant · 2 generations on · 517 of its ownK042000 Modified MSQ Family of Lovely Light/Laser SystemsMsq (M2), Ltd. · 2004
  5. Descendant · cites it directly · 403 of its ownK040103 Soundskin Phototherapy SystemBhc International, Ltd. · 2005
  6. Descendant · cites it directly · 402 of its ownK042630 Revlight Skin Care SystemSkincare Technology, Inc. · 2005

Showing 5 of 856 descendants. See all descendants

Descendants cleared per year

2003: 12004: 52005: 92006: 82007: 152008: 282009: 132010: 222011: 172012: 182013: 272014: 292015: 332016: 412017: 422018: 382019: 312020: 462021: 432022: 612023: 552024: 862025: 1182026: 70
2003high 118 (2025) · low 1 (2003)2026

Most influential descendants

Showing 5 of 856 · See all
  • K033946Lovely SystemMsq (M2), Ltd. · 2004 · cites it directly737descendants
  • K030883Omnilux BluePhoto Therapeutics Limited · 2003 · cites it directly524descendants
  • K042000Modified MSQ Family of Lovely Light/Laser SystemsMsq (M2), Ltd. · 2004 · 2 generations on517descendants
  • K040103Soundskin Phototherapy SystemBhc International, Ltd. · 2005 · cites it directly403descendants
  • K042630Revlight Skin Care SystemSkincare Technology, Inc. · 2005 · cites it directly402descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K013623Clearlight Phototheraphy System, Model CL 420Curelight, Ltd.2002—
+1K033946Lovely SystemMsq (M2), Ltd.2004—
+1K030883Omnilux BluePhoto Therapeutics Limited2003—
+2K042000Modified MSQ Family of Lovely Light/Laser SystemsMsq (M2), Ltd.2004—
+1K040103Soundskin Phototherapy SystemBhc International, Ltd.2005—
+1K042630Revlight Skin Care SystemSkincare Technology, Inc.2005—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200450
200590
200680
2007150
2008280
2009130
2010220
2011170
2012180
2013270
2014290
2015330
2016410
2017420
2018380
2019310
2020460
2021430
2022610
2023550
2024860
20251180
2026700
FIG. 1 — Lineage of K013623, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Avex Industries, Inc.’s Phototherapeutix
Named without a submission number
—
*—National Biological Corporation’s Derma-Wand
Named without a submission number
—
*—PhotoMedex, Inc.’s XTrac Excimer Laser System, Model AL 7000
Named without a submission number
—
*—Respironics, Inc.’s Wallaby 3 Phototherapy System
Named without a submission number
—

What descends from it? (856)

See all 856

10 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K033946Lovely SystemMsq (M2), Ltd.2004737
K030883Omnilux BluePhoto Therapeutics Limited2003524
K040103Soundskin Phototherapy SystemBhc International, Ltd.2005403
K042630Revlight Skin Care SystemSkincare Technology, Inc.2005402
K043329Omnilux Revive and BluePhoto Therapeutics Limited2005202
K043377ZENOTyrell, Inc.2005142
K043575Dermillume, Model PRO1000Care Electronics, Inc.20054
K060567Spectragenics Ats-1Spectragenics, Inc.20062
K032514AC Applicator, Aurora ACSyneron Medical, Ltd.20041
K070870Skin Care LightTransverse Industries Co.20070

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K033946 (Msq (M2), Ltd., 2004) has gone furthest, with 737 descendants of its own.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The ClearLight Phototherapy System is intended to provide phototherapeutic light to the body. The ClearLight is generally indicated to treat dermatological conditions. The ClearLight is specifically indicated to treat moderate inflammatory acne vulgaris.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K013623: Clearlight Phototheraphy System, Model CL 420.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K013623

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026